Alexandra R Lovell1, Michael E Ernst2,3. 1. Department of Pharmacy Practice and Science, College of Pharmacy, The University of Iowa, Iowa City, IA, USA. 2. Department of Pharmacy Practice and Science, College of Pharmacy, The University of Iowa, Iowa City, IA, USA. michael-ernst@uiowa.edu. 3. Department of Family Medicine, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA. michael-ernst@uiowa.edu.
Abstract
PURPOSE OF REVIEW: This review is intended to briefly describe the primary mechanistic pathways by which several common drugs can increase blood pressure. We also propose potential management strategies based on the underlying mechanisms responsible for the blood pressure elevation. RECENT FINDINGS: As hypertension is a significant risk factor for cardiovascular events, healthcare providers must evaluate patients' concomitant medications that may contribute to elevations in blood pressure. The presence of these medications, if not properly addressed, can lead to consequences such as an inadvertent diagnosis of hypertension, as well as the potential need for unnecessary intensification of antihypertensive regimens in those already treated. Blood pressure elevation is an unfortunate by-product of multiple medications. The substances discussed in this review can elicit significant and persistent elevations in blood pressure, and health care providers must first evaluate whether the drug is necessary. If one exists, it is best to select a similar agent with lower risk of increasing blood pressure; if unavoidable, then clinicians should select an appropriate management strategy to compensate for the rise in blood pressure.
PURPOSE OF REVIEW: This review is intended to briefly describe the primary mechanistic pathways by which several common drugs can increase blood pressure. We also propose potential management strategies based on the underlying mechanisms responsible for the blood pressure elevation. RECENT FINDINGS: As hypertension is a significant risk factor for cardiovascular events, healthcare providers must evaluate patients' concomitant medications that may contribute to elevations in blood pressure. The presence of these medications, if not properly addressed, can lead to consequences such as an inadvertent diagnosis of hypertension, as well as the potential need for unnecessary intensification of antihypertensive regimens in those already treated. Blood pressure elevation is an unfortunate by-product of multiple medications. The substances discussed in this review can elicit significant and persistent elevations in blood pressure, and health care providers must first evaluate whether the drug is necessary. If one exists, it is best to select a similar agent with lower risk of increasing blood pressure; if unavoidable, then clinicians should select an appropriate management strategy to compensate for the rise in blood pressure.
Authors: Gregory R Sayer; James J McGough; Jennifer Levitt; Jennifer Cowen; Alexandra Sturm; Edward Castelo; James T McCracken Journal: J Child Adolesc Psychopharmacol Date: 2016-08-02 Impact factor: 2.576
Authors: L Chasan-Taber; W C Willett; J E Manson; D Spiegelman; D J Hunter; G Curhan; G A Colditz; M J Stampfer Journal: Circulation Date: 1996-08-01 Impact factor: 29.690
Authors: Márcia N de Carvalho; Fernando Nobre; Maria C Mendes; Rosana M Dos Reis; Rui A Ferriani; Marcos F Silva de Sá Journal: Blood Press Monit Date: 2008-10 Impact factor: 1.444
Authors: J Graham; T Banaschewski; J Buitelaar; D Coghill; M Danckaerts; R W Dittmann; M Döpfner; R Hamilton; C Hollis; M Holtmann; M Hulpke-Wette; M Lecendreux; E Rosenthal; A Rothenberger; P Santosh; J Sergeant; E Simonoff; E Sonuga-Barke; I C K Wong; A Zuddas; H-C Steinhausen; E Taylor Journal: Eur Child Adolesc Psychiatry Date: 2010-11-03 Impact factor: 4.785
Authors: Manuel Wallbach; Nadine Lach; Johanna Stock; Henrik Hiller; Eirini Mavropoulou; Myra-Lynn Chavanon; Hartmud Neurath; Sabine Blaschke; Elena Lowin; Christoph Herrmann-Lingen; Gerhard A Müller; Michael J Koziolek Journal: J Clin Hypertens (Greenwich) Date: 2018-12-05 Impact factor: 3.738